PERSONAL CFO SOLUTIONS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1677501
CHESTER, NJ
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,053,067
+$358,698 QoQ
Shares Held
2,120
+36.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#830
of 1,726 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $4,413,711 across 7 Biotechnology names. VRTX ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,692 | $1,055,029 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,120 | $1,053,067 | |
| 3 | INCY |
Incyte Corp
|
7,701 | $872,985 | |
| 4 | ABVX |
Abivax S.A.
|
3,313 | $441,490 | |
| 5 | EXEL |
Exelixis, Inc.
|
7,252 | $394,581 | |
| 6 | ASND |
Ascendis Pharma A/S
|
1,441 | $384,343 | |
| 7 | DBVT |
DBV Technologies S.A.
|
12,940 | $212,216 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,053,067 | 2,120 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $694,369 | 1,555 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $609,315 | 1,344 | Shares | Defined | 2026-01-22 | |
| 2025-09-30 | $461,743 | 1,179 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $506,192 | 1,137 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $561,906 | 1,159 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $429,680 | 1,067 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $319,509 | 687 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $310,761 | 663 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $277,976 | 665 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $402,414 | 989 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $369,647 | 1,063 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $274,137 | 779 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $267,179 | 848 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $274,341 | 950 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $274,483 | 948 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $266,291 | 945 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $455,653 | 1,746 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $202,910 | 924 | Shares | Defined | 2022-02-11 | |
| 2021-03-31 | $288,382 | 1,342 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $210,106 | 889 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $240,009 | 882 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $212,797 | 733 | Shares | Defined | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||